Probiotics, prebiotics, synbiotics and insulin sensitivity (Q47645890)

4 February 2018

title

Probiotics, prebiotics, synbiotics and insulin sensitivity (English)

1 reference

4 February 2018

0 references

Y A Kim

1

1 reference

4 February 2018

J B Keogh

series ordinal

2

1 reference

4 February 2018

P M Clifton

series ordinal

3

1 reference

4 February 2018

publication date

17 October 2017

1 reference

4 February 2018

Nutrition Research Reviews

published in

1 reference

4 February 2018

page(s)

1-17

1 reference

4 February 2018

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Resistant starch type 4-enriched diet lowered blood cholesterols and improved body composition in a double blind controlled cross-over intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Efficacy of increased resistant starch consumption in human type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The inclusion of a partial meal replacement with or without inulin to a calorie restricted diet contributes to reach recommended intakes of micronutrients and decrease plasma triglycerides: a randomized clinical trial in obese Mexican women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Yacon syrup: beneficial effects on obesity and insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Resistant starch improves insulin sensitivity in metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The therapeutic use of symbiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Energetics and kinetics of lactate fermentation to acetate and propionate via methylmalonyl-CoA or acrylyl-CoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Metabolic Pathways Associated with Kimchi, a Traditional Korean Food, Based on In Silico Modeling of Published Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Beneficial effects of fresh and fermented kimchi in prediabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients--a randomized double-blind placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Molecular characterisation of the faecal microbiota in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotic mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels While Increasing HDL Levels in Serum from Patients with Type-2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The Consumption of Synbiotic Bread Containing Lactobacillus sporogenes and Inulin Affects Nitric Oxide and Malondialdehyde in Patients with Type 2 Diabetes Mellitus: Randomized, Double-Blind, Placebo-Controlled Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

STAMPing out Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS095442241700018X

21 January 2018

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The prebiotic source influences the growth, biochemical features and survival under simulated gastrointestinal conditions of the probiotic Lactobacillus acidophilus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Nutrient control of energy homeostasis via gut-brain neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Genetic and environmental control of host-gut microbiota interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: description of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotic yogurt improves antioxidant status in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Role of nitric oxide in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Long-term complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Global estimates of diabetes prevalence for 2013 and projections for 2035.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Interaction between obesity and the gut microbiota: relevance in nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Short chain fatty acids and their receptors: new metabolic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Glucagon-like peptide 1 and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

The Intestinal Microbiota in Metabolic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Do probiotics act more efficiently in foods than in supplements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

Effect of Prebiotic Supplementation and Calcium Intake on Body Mass Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

The prevention or delay of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Kimchi and Other Widely Consumed Traditional Fermented Foods of Korea: A Review

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3.

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers

1 reference

https://api.crossref.org/works/10.1017%2FS095442241700018X

7 January 2021

10.1017/S095442241700018X

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018